Bio-Rad Laboratories BIO Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's net change in cash?
- Bio-Rad Laboratories (BIO) reported net change in cash of -$23.2M in Q1 2026.
- How has Bio-Rad Laboratories's net change in cash changed year-over-year?
- Bio-Rad Laboratories's net change in cash decreased by 169.7% year-over-year, from $33.3M to -$23.2M.
- What is the long-term trend for Bio-Rad Laboratories's net change in cash?
- Over 2 years (2021 to 2025), Bio-Rad Laboratories's net change in cash has grown at a -53.5% compound annual growth rate (CAGR), from -$195.98M to $42.4M.
- What does net change in cash mean?
- The total change in the company's cash balance during the period.
- How do you interpret net change in cash?
- A positive value indicates net cash accumulation, suggesting strong liquidity or capital raising, while a negative value indicates cash burn or significant capital deployment.
- How does net change in cash compare across companies?
- A standard line item found in the cash flow statement of every public company.